dc.contributor.author |
Nasri, Masoud |
|
dc.contributor.author |
Ritter, Malte |
|
dc.contributor.author |
Mir, Perihan |
|
dc.contributor.author |
Dannenmann, Benjamin |
|
dc.contributor.author |
Arreba-Tutusaus, Patricia |
|
dc.contributor.author |
Xu, Yun |
|
dc.contributor.author |
Borbaran-Bravo, Natalia |
|
dc.contributor.author |
Klimiankou, Maksim |
|
dc.contributor.author |
Lengerke, Claudia |
|
dc.contributor.author |
Zeidler, Cornelia |
|
dc.contributor.author |
Welte, Karl |
|
dc.contributor.author |
Skokowa, Julia |
|
dc.date.accessioned |
2025-01-22T15:09:14Z |
|
dc.date.available |
2025-01-22T15:09:14Z |
|
dc.date.issued |
2024 |
|
dc.identifier.issn |
1525-0016 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/160562 |
|
dc.language.iso |
en |
en |
dc.publisher |
Cambridge : Cell Press |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1016/j.ymthe.2024.03.037 |
|
dc.subject.ddc |
570 |
de_DE |
dc.subject.ddc |
610 |
de_DE |
dc.title |
CRISPR-Cas9n-mediated ELANE promoter editing for gene therapy of severe congenital neutropenia |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20241001000000_01213 |
|
utue.publikation.seiten |
1628-1642 |
de_DE |
utue.personen.roh |
Nasri, Masoud |
|
utue.personen.roh |
Ritter, Malte U. |
|
utue.personen.roh |
Mir, Perihan |
|
utue.personen.roh |
Dannenmann, Benjamin |
|
utue.personen.roh |
Kaufmann, Masako M. |
|
utue.personen.roh |
Arreba-Tutusaus, Patricia |
|
utue.personen.roh |
Xu, Yun |
|
utue.personen.roh |
Borbaran-Bravo, Natalia |
|
utue.personen.roh |
Klimiankou, Maksim |
|
utue.personen.roh |
Lengerke, Claudia |
|
utue.personen.roh |
Zeidler, Cornelia |
|
utue.personen.roh |
Cathomen, Toni |
|
utue.personen.roh |
Welte, Karl |
|
utue.personen.roh |
Skokowa, Julia |
|
dcterms.isPartOf.ZSTitelID |
Molecular Therapy |
de_DE |
dcterms.isPartOf.ZS-Issue |
6 |
de_DE |
dcterms.isPartOf.ZS-Volume |
32 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
|